Table 1.
Clinical parameters according to TRPV1 expression categories
| Parameters | Classical
|
Nonclassical
|
P-value | Total |
|---|---|---|---|---|
| n (%) | n (%) | |||
|
| ||||
| T stage | ||||
| T1/T2 | 18 (62.0) | 11 (37.9) | 0.614 | 29 |
| T3/T4 | 3 (75) | 1 (25) | 0.741 | 4 |
| N stage | ||||
| N1 | 10 (66.6) | 5 (33.3) | 0.741 | 15 |
| N2–3 | 11 (61.1) | 7 (38.8) | 0.029a | 18 |
| Clinical stage | ||||
| I/II | 10 (66.6) | 5 (33.3) | 0.060 | 15 |
| III/IV | 11 (61.1) | 7 (38.8) | 18 | |
| St. Gallen | ||||
| Lower malignancy (LA+LB) | 19 (73.1) | 7 (26.9) | 26 | |
| Higher malignancy (HER2+TN) | 2 (28.5) | 5 (71.5) | 7 | |
| Death | ||||
| No | 17 (73.9) | 6 (26.0) | 23 | |
| Yes | 4 (40.0) | 6 (60.0) | 10 | |
| Total | 21 | 12 | 33 | |
Note:
a
Significant association of the frequency of nonclassical pattern with higher malignancy St. Gallen subtypes.